Cannabidiol May Be a Potential Treatment for Fragile X Syndrome
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the recent publication of a paper entitled, “Role of the Endocannabinoid System in Fragile X Syndrome: Potential Mechanisms for Benefit From …
Cannabidiol May Be a Potential Treatment for Fragile X Syndrome Read More